Print

Catabasis Pharmaceuticals, Inc. to Present at Parent Project Muscular Dystrophy (PPMD) Annual Connect Conference  
6/6/2012 10:02:01 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines for the treatment of inflammatory and metabolic diseases, today announced that Michael Jirousek, Ph.D., chief scientific officer and co-founder of Catabasis, will present at the Parent Project Muscular Dystrophy (PPMD) Annual Connect Conference to be held June 28-July 1, 2012 at the Harbor Beach Marriott Hotel in Ft. Lauderdale, Fla.
//-->